Predicting breast cancer with the BRAVE system
Part of Cancer, Skin clinical trials.
This trial is testing a new way to predict breast cancer risk using breast density from your recent mammogram. It may help people with a new breast finding and who haven't had prior breast procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You've had a mammogram in the last 6 months
- You have a new breast lump or finding that needs more testing
- Your mammogram report shows your breast density is either A, B, C, or D
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This trial offers extra screening (MRI or contrast-enhanced mammogram) for women with extremely dense breast tissue who have had a normal mammogram. The goal is to see if these extra tests can find cancers that might be missed by standard mammography.
This trial compares two imaging tests—CESM (a contrast-enhanced mammogram) and DBT (3D mammography)—to see which works best for women with dense breast tissue. It may help improve how early breast changes are found in dense breasts.
This study looks at breast cancer risk by analyzing what is seen in dense breast tissue during a screening ultrasound. It may help improve how doctors evaluate risk in people with very dense breasts.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.